[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100300625":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":33,"locations":40,"responsibleParty":57,"collaborators":38,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":38,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":38,"maxAge":38,"enrollmentInfo":68,"targetDuration":38,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":38,"overallStatus":77,"whyStopped":38,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Tanta University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Portal Vein thrombosis","EXPERIMENTAL","rivaroxaban",[13],"Drug: rivaroxaban",[15],{"type":16,"name":11,"description":11,"armGroupLabels":17,"otherNames":18},"DRUG",[9],[19],"xarelto",[21,25,29],{"name":22,"affiliation":23,"role":24},"Amr Hanafy, Professor","Hepatology unit - Zagazig University","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":27,"role":28},"Mohamed Basha, Consultant","Radiology Dept - Zagazig University","STUDY_DIRECTOR",{"name":30,"affiliation":31,"role":32},"Sherief Abd-elsalam, consultant","Hepatology - Gastroenterology - Tanta University","STUDY_CHAIR",[34],{"name":35,"role":36,"phone":37,"phoneExt":38,"email":39},"Sherief Abd-Elsalam, consultant","CONTACT","00201095159522",null,"Sheriefabdelsalam@yahoo.com",[41],{"facility":42,"status":43,"city":44,"state":38,"zip":38,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Tropical medicine dept.-Tanta university hospital","RECRUITING","Cairo","Egypt","EG",{"type":48,"coordinates":49},"Point",[50,51],31.24967,30.06263,{"lat":51,"lon":50},[54],{"name":55,"role":36,"phone":37,"phoneExt":38,"email":56},"Sherief Abd-Elsalam","Sherif_tropical@yahoo.com",{"type":58,"investigatorFullName":55,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":38,"oldOrganization":38},"SPONSOR_INVESTIGATOR","Consultant","100300625","phase-3-efficacy-and-safety-of-rivaroxaban-in-the-management-of-acute-non-neoplastic-pvt-compensated-cirrhosis-100300625",false,"NCT03193502","Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis","Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic Portal Vein Thrombosis in HCV Related Compensated Cirrhosis","Inclusion Criteria:\n\n* Acute PVT\n\nExclusion Criteria:\n\n* Malignant PVT\n* Bleeding disorders","ALL",{"count":69,"type":70},40,"ESTIMATED","INTERVENTIONAL",[73],"PHASE3","-Rivaroxaban is factor Xa inhibitor",[76],"Portal Vein Thrombosis","UNKNOWN","2017-10-12",{"date":80,"type":81},"2017-10-13","ACTUAL",{"date":83,"type":81},"2014-05-01",{"date":85,"type":70},"2020-12",{"name":55,"class":6},1]